Editorial comment on: Short-acting β 2-agonist use and asthma exacerbations in Swedish children: A SABINA Junior study

Pediatr Allergy Immunol. 2023 Jan;34(1):e13910. doi: 10.1111/pai.13910.

Authors

Cristina Boccabella¹, Omer Kalayci², Philippe Eigenmann³

Affiliations

¹ Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario "A Gemelli" - IRCCS, University of the Sacred Heart, Rome, Italy.
² Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey.
³ Pediatric Allergy Unit, Department of Women-Children-Teenagers, University Hospitals of Geneva, Geneva, Switzerland.

PMID: 36705044
DOI: 10.1111/pai.13910

No abstract available

Publication types

Editorial

MeSH terms

Administration, Inhalation
Adrenal Cortex Hormones / therapeutic use
Anti-Asthmatic Agents* / therapeutic use
Asthma* / drug therapy
Asthma* / epidemiology
Bronchodilator Agents / therapeutic use
Child
Humans
Sweden / epidemiology

Substances

Bronchodilator Agents
Anti-Asthmatic Agents
Adrenal Cortex Hormones